The Efficacy and Tolerability of Acarbose in Healthy Individuals

Clinical trial NCT05542849 · COMPLETED

Trial details

NCT number: NCT05542849
Sponsor: AgelessRx
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Tolerance Side Effect Glucose Response

Start date: 2022-08-10
Primary completion: 2022-10-05
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.